Advanced technology company Phoenix opens first phase of Fitchburg campus
SHELLEY K. MESCH smesch@madison.com Evan Sengbusch, center back, and attendees at the Phoenix Neutron Imaging Center grand opening view a neutron collimation system. The system directs neutrons from the center out toward 10 different imaging areas, allowing the...myTAIHEART Test Provides Evidence for Injury from Biopsy of Heart Transplant Recipients
MILWAUKEE, Wis.–(BUSINESS WIRE)–TAI Diagnostics, Inc., focused on developing innovative diagnostic tests for monitoring the health of transplanted organs, today announced the publication, “Effect of endomyocardial biopsy on levels of donor-specific cell-free DNA” in the October, 2019 issue of The Journal of Heart and Lung Transplantation. The clinical study presented in the paper was conducted jointly by Steven Zangwill, MD, Karl Stamm, PhD, Mats Hidestrand, PhD, Aoy Tomita-Mitchell, PhD and Michael Mitchell, MD.
Recent Comments